US Patent 11779641 Tolerogenic synthetic nanocarriers for allergy therapy
Patent 11779641 was granted and assigned to SELECTA BIOSCIENCES INC on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+60 properties)
Article (+235 characters)
US Patent 11779641 Tolerogenic synthetic nanocarriers for allergy therapy
Article
Patent abstract
Disclosed are synthetic nanocarrier compositions, and related methods, comprising immunosuppressants and MHC Class II-restricted epitopes of an allergen that provide tolerogenic immune responses specific to the allergen.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christopher Fraser
Roberto A. Maldonado
Takashi Kei Kishimoto
Date of Patent
October 10, 2023
Patent Application Number
15061204
Date Filed
March 4, 2016
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11779641 Tolerogenic synthetic nanocarriers for allergy therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
